189 related articles for article (PubMed ID: 37350559)
1. Estimates of bladder cancer burden attributable to high fasting plasma glucose: Findings of the Global Burden of Disease Study 2019.
Wu Y; Deng Y; Dai Z; Ma Y; Lyu L; Lei C; Zheng Y; Li Y; Wang Z; Gao J
Cancer Med; 2023 Aug; 12(15):16469-16481. PubMed ID: 37350559
[TBL] [Abstract][Full Text] [Related]
2. Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease study 2019.
Safiri S; Kolahi AA; Naghavi M;
BMJ Glob Health; 2021 Nov; 6(11):. PubMed ID: 34844997
[TBL] [Abstract][Full Text] [Related]
3. Burden of cancers attributable to high fasting plasma glucose in the Middle East and North Africa region, 1990-2019.
Tondro Anamag F; Noori M; Nejadghaderi SA; Sullman MJM; Grieger JA; Kolahi AA; Safiri S
Cancer Med; 2023 Apr; 12(8):10031-10044. PubMed ID: 36951550
[TBL] [Abstract][Full Text] [Related]
4. Global, regional, and national cancer deaths and disability-adjusted life-years (DALYs) attributable to alcohol consumption in 204 countries and territories, 1990-2019.
Safiri S; Nejadghaderi SA; Karamzad N; Carson-Chahhoud K; Bragazzi NL; Sullman MJM; Almasi-Hashiani A; Mansournia MA; Collins GS; Kaufman JS; Kolahi AA
Cancer; 2022 May; 128(9):1840-1852. PubMed ID: 35239973
[TBL] [Abstract][Full Text] [Related]
5. Burden of chronic kidney disease and its risk-attributable burden in 137 low-and middle-income countries, 1990-2019: results from the global burden of disease study 2019.
Ke C; Liang J; Liu M; Liu S; Wang C
BMC Nephrol; 2022 Jan; 23(1):17. PubMed ID: 34986789
[TBL] [Abstract][Full Text] [Related]
6. Burden of Tracheal, Bronchus, and Lung Cancer and Its Attributable Risk Factors in 204 Countries and Territories, 1990 to 2019.
Safiri S; Sohrabi MR; Carson-Chahhoud K; Bettampadi D; Taghizadieh A; Almasi-Hashiani A; Ashrafi-Asgarabad A; Sepidarkish M; Eagen A; Mansournia MA; Kolahi AA
J Thorac Oncol; 2021 Jun; 16(6):945-959. PubMed ID: 33866016
[TBL] [Abstract][Full Text] [Related]
7. Global, regional, and national burden of ovarian cancer and the attributable risk factors in all 194 countries and territories during 2007-2017: A systematic analysis of the Global Burden of Disease Study 2017.
Yang D; Huang H; Ruan T; Yang H; Hu J; Xu S; Ling S; Yu Y
J Obstet Gynaecol Res; 2021 Dec; 47(12):4389-4402. PubMed ID: 34674356
[TBL] [Abstract][Full Text] [Related]
8. Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019.
Safiri S; Nejadghaderi SA; Karamzad N; Kaufman JS; Carson-Chahhoud K; Bragazzi NL; Sullman MJM; Beyranvand MR; Mansournia MA; Almasi-Hashiani A; Collins GS; Kolahi AA
Front Endocrinol (Lausanne); 2022; 13():879890. PubMed ID: 35966097
[TBL] [Abstract][Full Text] [Related]
9. The global burden of disease attributable to high body mass index in 195 countries and territories, 1990-2017: An analysis of the Global Burden of Disease Study.
Dai H; Alsalhe TA; Chalghaf N; Riccò M; Bragazzi NL; Wu J
PLoS Med; 2020 Jul; 17(7):e1003198. PubMed ID: 32722671
[TBL] [Abstract][Full Text] [Related]
10. Global burden of pancreatic cancer attributable to metabolic risks from 1990 to 2019, with projections of mortality to 2030.
He R; Jiang W; Wang C; Li X; Zhou W
BMC Public Health; 2024 Feb; 24(1):456. PubMed ID: 38350909
[TBL] [Abstract][Full Text] [Related]
11. Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990-2019.
Zi H; He SH; Leng XY; Xu XF; Huang Q; Weng H; Zhu C; Li LY; Gu JM; Li XH; Ming DJ; Li XD; Yuan S; Wang XH; He DL; Zeng XT
Mil Med Res; 2021 Nov; 8(1):60. PubMed ID: 34819142
[TBL] [Abstract][Full Text] [Related]
12. Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990-2019: analysis of data from the 2019 Global Burden of Disease Study.
Li Z; Yang N; He L; Wang J; Ping F; Li W; Xu L; Zhang H; Li Y
Diabetol Metab Syndr; 2023 Jan; 15(1):6. PubMed ID: 36647090
[TBL] [Abstract][Full Text] [Related]
13. The global burden of disease attributable to high fasting plasma glucose in 204 countries and territories, 1990-2019: An updated analysis for the Global Burden of Disease Study 2019.
Liang R; Feng X; Shi D; Yang M; Yu L; Liu W; Zhou M; Wang X; Qiu W; Fan L; Wang B; Chen W
Diabetes Metab Res Rev; 2022 Nov; 38(8):e3572. PubMed ID: 36001650
[TBL] [Abstract][Full Text] [Related]
14. Estimating the changing burden of disease attributable to high fasting plasma glucose in South Africa for 2000, 2006 and 2012.
Pillay van-Wyk V; Cois A; Kengne AP; Roomaney RA; Levitt N; Turawa EB; Abdelatief N; Neethling I; Awotiwon OF; Nojilana B; Joubert JD; Pacella R; Bradshaw D
S Afr Med J; 2022 Sep; 112(8b):594-606. PubMed ID: 36458353
[TBL] [Abstract][Full Text] [Related]
15. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
GBD 2015 Chronic Respiratory Disease Collaborators
Lancet Respir Med; 2017 Sep; 5(9):691-706. PubMed ID: 28822787
[TBL] [Abstract][Full Text] [Related]
16. The burden of young-onset pancreatic cancer and its risk factors from 1990 to 2019: A systematic analysis of the global burden of disease study 2019.
Dahia SS; Konduru L; Pandol SJ; Barreto SG
Pancreatology; 2024 Feb; 24(1):119-129. PubMed ID: 38151359
[TBL] [Abstract][Full Text] [Related]
17. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
GBD 2016 DALYs and HALE Collaborators
Lancet; 2017 Sep; 390(10100):1260-1344. PubMed ID: 28919118
[TBL] [Abstract][Full Text] [Related]
18. The global burden of ischemic heart disease attributed to high fasting plasma glucose: Data from 1990 to 2019.
Shen N; Liu J; Wang Y; Qiu Y; Li D; Wang Q; Chai L; Chen Y; Hu H; Li M
Heliyon; 2024 Mar; 10(5):e27065. PubMed ID: 38495138
[TBL] [Abstract][Full Text] [Related]
19. [Burden of disease attributable to high fasting plasma glucose in 1990 and 2013 in China].
Zhao YF; Wang ZQ; Yang J; Li YC; Yin P; You JL; Zhou MG
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Sep; 50(9):769-775. PubMed ID: 27655595
[No Abstract] [Full Text] [Related]
20. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.
GBD 2015 Tobacco Collaborators
Lancet; 2017 May; 389(10082):1885-1906. PubMed ID: 28390697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
